Purity and the dangers of regenerative medicine: Regulatory innovation of human tissue-engineered technology
暂无分享,去创建一个
Julie Kent | Alex Faulkner | A. Faulkner | I. Geesink | J. Kent | David FitzPatrick | Ingrid Geesink | David FitzPatrick
[1] A. Buckley. Walls within Walls Religion and Rough Behaviour in an Ulster Community , 1984 .
[2] W. Godwin. Article in Press , 2000 .
[3] A. Faulkner,et al. Innovation and regulation in human implant technologies: developing comparative approaches. , 2001, Social science & medicine.
[4] M. Sefton,et al. Tissue engineering. , 1998, Journal of cutaneous medicine and surgery.
[5] Martin Bauer. Resistance to New Technology: Nuclear Power, Information Technology, Biotechnology , 1995 .
[6] A. Barry. Political Machines: Governing a Technological Society , 2001 .
[7] A. Rosoff. THE GOLD STANDARD: THE CHALLENGE OF EVIDENCE-BASED MEDICINE AND STANDARDIZATION IN HEALTH CARE , 2004 .
[8] Tiago Moreira,et al. Diversity in clinical guidelines: the role of repertoires of evaluation. , 2005, Social science & medicine.
[9] A. Faulkner,et al. Towards governance of human tissue engineered technologies in Europe: Framing the case for a new regulatory regime , 2006 .
[10] A. Appadurai. Disjuncture and Difference in the Global Cultural Economy , 1990 .
[11] Mike Michael,et al. Regulating Hybrids: ‘Making a Mess’ and ‘Cleaning Up’ in Tissue Engineering and Transpecies Transplantation , 2006, Social theory & health : STH.
[12] Stuart S. Blume,et al. Technology Assessment and the Sociopolitics of Health Technologies , 2000, Journal of health politics, policy and law.
[13] Dott.ssa Margherita Daverio. European Group on Ethics in Science and New Technologies. , 1998, Human reproduction and genetic ethics.
[14] Andrew Webster,et al. New Medical Technologies and Society: Reordering Life , 2004 .
[15] R. Evans,et al. Xenotransplantation, risk, regulation and surveillance: social and technological dimensions of change , 1999 .
[16] M. Strathern. Property, Substance and Effect: Anthropological Essays on Persons and Things , 1999 .
[17] M. Traynor. The oil crisis, risk and evidence-based practice. , 2002, Nursing inquiry.
[18] Julie Kent,et al. Culturing Cells, Reproducing and Regulating the Self , 2006 .
[19] Carl May,et al. Factors affecting the adoption of telehealthcare in the United Kingdom: the policy context and the problem of evidence , 2001 .
[20] M. Lock,et al. Remaking life and death: Toward an Anthropology of the Biosciences , 2003 .
[21] Mike Michael,et al. Risky creatures: Institutional species boundary change in biotechnology regulation , 2004 .
[22] M. Douglas,et al. Purity and Danger: An Analysis of Concepts of Pollution and Taboo. , 1967 .
[23] Harold G. Wolff,et al. Social Science in Medicine , 1955, The Yale Journal of Biology and Medicine.
[24] Julie Kent,et al. Human tissue engineered products—drugs or devices? , 2003, BMJ : British Medical Journal.
[25] J. Overhage,et al. Sorting Things Out: Classification and Its Consequences , 2001, Annals of Internal Medicine.
[26] Giandomenico Majone,et al. The new European agencies: regulation by information , 1997 .
[27] D. Vogel. The new politics of risk regulation in Europe , 2001 .